1.
Gordon K, Eyerich K, Anadkat M, Choon SE, Elewski B, Barker J, Mostaghimi A, Tang M, Haeufel T, Thoma C, Thaci D. Low Occurrence of Predefined Safety Events Across Six Randomized Clinical Trials of Spesolimab in Dermatologic Conditions. J of Skin [Internet]. 2024Jul.23 [cited 2024Jul.23];8(4):s410. Available from: https://jofskin.org/index.php/skin/article/view/2876